Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of Anticalin-based drugs. Its pipeline includes immuno-oncology, respiratory, and anemia and other disease areas. The company was founded by Claus Schalper and Arne Skerra in 2001 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
14
Frequently Asked Questions
What is Market Cap of Pieris Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Pieris Pharmaceuticals Inc market cap is $149.85M.
What is the 52-week high for Pieris Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Pieris Pharmaceuticals Inc 52 week high is $18.68 as of September 06, 2025.
What is the 52-week low for Pieris Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Pieris Pharmaceuticals Inc 52 week low is $6.20 as of September 06, 2025.
What is Pieris Pharmaceuticals Inc stock price today?
Pieris Pharmaceuticals Inc stock price today is $13.60.
What was Pieris Pharmaceuticals Inc stock price yesterday?
Pieris Pharmaceuticals Inc stock price yesterday was $16.13.
What is the PE ratio of Pieris Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Pieris Pharmaceuticals Inc’s P/E ratio is -1.08.
What is the Price-to-Book ratio of Pieris Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Pieris Pharmaceuticals Inc P/B ratio is 1.1037.
What is the 50-day moving average of Pieris Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Pieris Pharmaceuticals Inc 50-day moving average is $13.60.
How many employess does Pieris Pharmaceuticals Inc has?
